Sign In
Buy SLNO
$53.01
+0 (+0%)
At Close: Jun 23, 2026
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:22pm, Friday, 03'rd Apr 2026
BENSALEM, Pa., April 3, 2026 /PRNewswire/ -- The Law Offices of Howard G.
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 20
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:27am, Friday, 03'rd Apr 2026
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. (“S
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options If you purchased or acquired
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
06:19pm, Thursday, 02'nd Apr 2026
SAN FRANCISCO, April 02, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno
Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline
06:15pm, Thursday, 02'nd Apr 2026
Did you buy SLNO common stock between March 26, 2025, and November 4, 202 5? Affected Soleno Therapeutics, Inc. Investor Summary Who: Soleno Therapeutics, Inc. (NASDAQ: SLNO) What: Securities fraud c
New York, New York--(Newsfile Corp. - April 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between M
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such inve
REMINDER: Soleno Therapeutics, Inc. Investors With Significant Losses Must Act By May 5, 2026 – Contact Kirby McInerney
08:00pm, Wednesday, 01'st Apr 2026
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors of the May 5, 2026 deadline to seek the r
New York, New York--(Newsfile Corp. - April 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between Marc
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:24pm, Wednesday, 01'st Apr 2026
LOS ANGELES, April 1, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) have o
Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman
03:43pm, Wednesday, 01'st Apr 2026
SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno commo
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025? Affected Soleno Therapeutics, Inc. Investor Summary Who: Soleno Therapeutics, Inc. (NASDAQ: SLNO) What: Securities fraud c
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
09:41am, Wednesday, 01'st Apr 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options
Alert: Claims Focus on Alleged Misrepresentations About Clinical Trial Integrity and Drug Safety NEW YORK, April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics
